Using Beta Blockers to Treat Mitral Regurgitation

Stopped early · Phase 1

Conditions studied: Heart Disease, Mitral Regurgitation, Heart Valve Disease, Mitral Valve Insufficiency

In brief

The purpose of this study tests whether beta-blocker will benefit asymptomatic patients with chronic primary mitral regurgitation.

Key facts

Study ID

NCT00700947

Run by

Wake Forest University Health Sciences

People needed

27

Starts

2007-10-01

Expected to finish

2009-09-01

Last updated by the study team

2018-08-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Diagnosis of sever primary mitral regurgitation
• Normal subjects

You may not qualify if…

• Left ventricle ejection fraction of <55% pre and post operation
• Pregnancy or Lactation
• Secondary mitral regurgitation due to coronary artery disease, cardiomyopathy, uncontrolled hypertension, or severe aortic stenosis.

Where it is running

• Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.